Montefiore Medical Center
The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
Glaucoma is the leading cause of irreversible blindness worldwide, and its treatment consists of lowering intraocular pressure to prevent damage to the optic nerve and loss of vision. Current methods for lowering intraocular pressure (IOP) include topical and oral medications, laser trabeculoplasty, microincisional glaucoma surgery (MIGS), and traditional incisional surgeries such as trabeculectomy and aqueous tube shunts. MIGS have become more popular in recent years as less invasive methods than traditional surgeries that effectively reduce IOP and help reduce the medication burden on patien…
Inclusion Criteria: * Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with KDB in a single surgical center at Montefiore Medical Center with a single provider Exclusion Criteria: * Patients with previous history of eye surgeries (including laser procedures)
pilocarpine hydrochloride ophthalmic solution 2% (20 mg/mL)
Prednisolone acetate ophthalmic suspension 1%
Ofloxacin Drops
Arctuva estimate
Verify or correct the compensation shown for this listing.